LOS ANGELES CAPITAL MANAGEMENT LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1177206
LOS ANGELES, CA
Position in HALO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$151,689,999
+$107,100,793 QoQ
Shares Held
1,938,035
+180.9% QoQ
Ownership
1.71%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#14
of 664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. HALO ranks #2 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
729,635 | $219,642,024 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
This page
|
1,938,035 | $151,689,999 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
3,958,531 | $70,541,022 | |
| 4 | INCY |
Incyte Corp
|
578,986 | $65,633,852 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130,802 | $64,973,277 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,159,457 | $63,086,055 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
98,585 | $61,471,690 | |
| 8 | RPRX |
Royalty Pharma plc
|
877,674 | $49,211,181 |
All Filings in HALO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $151,689,999 | 1,938,035 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $44,589,206 | 689,915 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $73,755,146 | 1,095,916 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $79,285,967 | 1,081,074 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $50,650,313 | 973,670 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,907,274 | 92,576 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $4,421,229 | 92,475 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $6,332,461 | 110,630 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $6,088,001 | 116,272 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $4,922,280 | 121,000 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $3,817,376 | 103,284 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,869,545 | 101,297 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $3,299,250 | 91,468 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,790,925 | 73,080 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $8,670,877 | 152,388 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $7,162,789 | 181,153 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $8,606,972 | 195,613 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $7,731,495 | 193,869 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $7,795,472 | 193,869 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $2,806,472 | 68,989 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,471,393 | 54,424 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,895,162 | 69,445 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $4,854,461 | 113,661 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $2,940,232 | 111,881 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $3,846,618 | 143,477 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,554,777 | 142,011 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||